Borgå O - Search Results

1

Techniques for plasma protein binding of demethylchlorimipramine.

Bertilsson L, Braithwaite R, Tybring G, Garle M, Borgå O. Bertilsson L, et al. Among authors: borga o. Clin Pharmacol Ther. 1979 Aug;26(2):265-71. doi: 10.1002/cpt1979262265. Clin Pharmacol Ther. 1979. PMID: 455895

2

Protein binding of enprofylline.

Tegnér K, Borgå O, Svensson I. Tegnér K, et al. Among authors: borga o. Eur J Clin Pharmacol. 1983;25(5):703-8. doi: 10.1007/BF00542362. Eur J Clin Pharmacol. 1983. PMID: 6420163

3

Plasma disappearance of transplacentally transferred diphenylhydantoin in the newborn studied by mass fragmentography.

Rane A, Garle M, Borgå O, Sjöqvist F. Rane A, et al. Among authors: borga o. Clin Pharmacol Ther. 1974 Jan;15(1):39-45. doi: 10.1002/cpt197415139. Clin Pharmacol Ther. 1974. PMID: 4808742 No abstract available.

4

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.

Odar-Cederlöf I, Borgå O. Odar-Cederlöf I, et al. Among authors: borga o. Eur J Clin Pharmacol. 1974;7(1):31-7. doi: 10.1007/BF00614387. Eur J Clin Pharmacol. 1974. PMID: 4852619 No abstract available.

5

The role of plasma protein binding in the inhibitory effect of nortriptyline on the neuronal uptake of norepinephrine.

Borgå O, Hamberger B, Malmfors T, Sjöqvist F. Borgå O, et al. Clin Pharmacol Ther. 1970 Jul-Aug;11(4):581-8. doi: 10.1002/cpt1970114581. Clin Pharmacol Ther. 1970. PMID: 5429182 No abstract available.

6

Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Borgå O, Piafsky KM, Nilsen OG. Borgå O, et al. Clin Pharmacol Ther. 1977 Nov;22(5 Pt 1):539-44. Clin Pharmacol Ther. 1977. PMID: 913020

7

Renal excretion of cephapirin and cephaloridine: evidence for saturable tubular reabsorption.

Arvidsson A, Borgå O, Alván G. Arvidsson A, et al. Among authors: borga o. Clin Pharmacol Ther. 1979 Jun;25(6):870-6. doi: 10.1002/cpt1979256870. Clin Pharmacol Ther. 1979. PMID: 445952

8

Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.

Borgå O, Hoppel C, Odar-Cederlöf I, Garle M. Borgå O, et al. Clin Pharmacol Ther. 1979 Sep;26(3):306-14. doi: 10.1002/cpt1979263306. Clin Pharmacol Ther. 1979. PMID: 466924

9

Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.

Odar-Cederlöf I, Borga O. Odar-Cederlöf I, et al. Among authors: borga o. Clin Pharmacol Ther. 1976 Jul;20(1):36-47. doi: 10.1002/cpt197620136. Clin Pharmacol Ther. 1976. PMID: 1277724

10

Plasma levels and protein binding of phenytoin during exercise in man: the effect of elevated free fatty acids.

Borgå O, Juhlin-Dannfeldt A, Dahlqvist R. Borgå O, et al. Pharmacology. 1978;16(1):37-43. doi: 10.1159/000136744. Pharmacology. 1978. PMID: 619360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results